查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826963

2025年全球OTC检测市场报告

Over The Counter Or OTC Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，OTC检测市场快速扩张，规模从2024年的241亿美元成长到2025年的274.7亿美元，复合年增长率为14.0%。预测期内的成长主要得益于智慧家庭医疗的兴起、远端患者监护的兴起、门诊诊所的兴起、行动医疗（ 行动医疗 ）解决方案的增长以及订阅式服务的兴起。

预计未来几年，OTC 检测市场将快速成长，到 2029 年将达到 459.6 亿美元，复合年增长率为 13.7%。预测期内成长的主要驱动因素包括感染疾病疫情的上升、爱滋病毒感染率的上升、远端患者监护的增加、智慧型手机的普及以及医疗相关感染 (HAIS) 的上升。预测期内的主要趋势包括数位健康整合、行动应用整合、综合护理模式、人工智慧和机器学习整合以及远端感染控制监控。

非处方 (OTC) 检测是指消费者无需处方笺即可购买和使用的诊断检测。这些检测专为自我管理而设计，允许个人监测和评估自身健康状况的各个方面，而无需就医。

非处方药 (OTC) 检测的主要类型包括胆固醇监测、尿液分析、药物滥用检测、传染病检查、大便潜血试验和血糖监测。胆固醇监测检测可测量血液胆固醇和血脂水平，以评估心臟健康并帮助预防心血管疾病。这些检测可应用于心臟病学、肿瘤学、血糖监测、怀孕和不孕症、感染疾病检测以及毒理学等领域。这些检测服务于各种终端用户，包括医院和诊所、居家医疗机构和诊断实验室。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗保健提供者正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。这些不断上涨的成本使医疗保健预算捉襟见肘，导致一些医疗机构推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，造成供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供OTC测试市场统计数据，例如全球市场规模、区域份额、竞争对手的OTC测试市场份额、详细的OTC测试细分市场、市场趋势以及OTC测试行业的商机。本OTC测试市场研究报告对行业现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整展望。

未来五年13.7%的成长率预测比我们先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会增加从中国和德国进口的COVID-19快速试纸的成本，从而扰乱美国消费者的医疗服务，导致预防性筛检减少和自付费用增加。由于互惠关税以及不断升级的贸易摩擦和贸易限制对全球经济和贸易的负面影响，其影响也将更加广泛。

慢性病盛行率的上升预计将推动非处方药 (OTC) 检测市场的成长。由于人口老化、不健康的生活方式、环境影响以及社会经济差距等因素，持续一年以上且需要持续医疗照护的慢性病正变得越来越普遍。 OTC 检测在慢性病管理中发挥关键作用，它能够实现早期发现，帮助个人监测自身健康状况，并促进及时干预，最终透过主动护理改善健康状况。例如，美国国家生物技术资讯中心 (NCBI) 在 2023 年 1 月预测，到 2050 年，患有至少一种慢性病的 50 岁及以上人群数量将增加 99.5%，从 2020 年的 7,152.2 万人增加到 1.4266 亿人。日益加重的疾病负担正在刺激对 OTC 诊断解决方案的需求。

非处方药 (OTC) 检测市场的主要企业正专注于开发家用检测套组，以提高消费者的便利性、准确性和可及性。家用检测套组可让消费者在家中舒适地诊断某些健康状况，并且通常可以透过血液、唾液或尿液样本快速获得结果。例如，2023 年 12 月，美国分子诊断公司 DiaCarta 的 iColon大便潜血试验检测 (FOBT) 获得美国FDA 510(k) 批准，并获得了 OTC核准。这项创新检测有助于早期发现粪便潜血，而潜血是胃肠道疾病和大肠癌（全球第三大常见癌症）的关键指标。 iColon FOBT 与 DiaCarta 现有的 ColoScape 检测相辅相成，进一步强化了其对早期癌症检测和治疗的承诺。

2024年12月，美国医疗设备製造商OraSure Technologies收购了Sherlock Biosciences，收购金额未揭露。此次策略收购旨在透过整合Sherlock先进的分子诊断平台，增强OraSure的诊断服务。该平台以一次性使用的形式提供快速且准确的结果，非常适合居家检测。此次收购符合OraSure透过创新检测解决方案改善医疗服务的可近性和可负担性的更广泛目标。总部位于美国的Sherlock Biosciences专注于非处方(OTC)一次性分子检测，尤其性行为感染感染(STI)。

非处方药 (OTC) 检测市场包括血糖值仪、指尖采血胆固醇检测套组、皮肤点刺过敏测试、血压计等产品的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球场外交易市场：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球OTC检测市场：成长率分析
  • 全球OTC检测市场表现：规模与成长，2019-2024年
  • 全球OTC检测市场预测：规模与成长，2024-2029年，2034年
  • 全球非处方药检测：总潜在市场（TAM）

第六章 市场细分

  • 全球非处方药检测市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 胆固醇监测测试
  • 尿液检查
  • 药物滥用检测
  • 传染病检查
  • 大便潜血试验
  • 血糖监测测试
  • 全球OTC检测市场：依应用、绩效及预测，2019-2024年、2024-2029年、2034年
  • 心臟病学
  • 肿瘤学
  • 血糖监测
  • 怀孕和生育能力
  • 感染疾病
  • 毒理学
  • 全球非处方药检测市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 居家护理
  • 诊断实验室
  • 其他最终用户
  • 全球非处方药检测市场：细分：胆固醇监测测试（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 总胆固醇检测
  • HDL（高密度脂蛋白）测试
  • LDL（低密度脂蛋白）测试
  • 三酸甘油酯检测
  • 全球非处方药检测市场：依尿液检查类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 尿液检查棒测试
  • 尿液显微镜检查
  • 尿液培养
  • 尿液妊娠试验
  • 全球非处方药检测市场：依药物滥用检测类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 尿液药物检测
  • 唾液毒品测试
  • 毛髮药物测试
  • 呼气毒品测试
  • 全球非处方药检测市场：依传染病检查类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • HIV检测
  • 肝炎检测
  • 流感检测
  • COVID-19检测
  • 链球菌咽头炎检查
  • 全球非处方药检测市场：大便潜血试验细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癒创木脂大便潜血试验（gFOBT）
  • 免疫化学大便潜血试验（iFOBT/FIT）
  • 全球非处方药检测市场：依血糖监测检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血糖仪
  • 持续血糖监测（CGM）系统
  • 尿糖试纸

第七章 区域和国家分析

  • 全球OTC检测市场：区域表现及预测（2019-2024年、2024-2029年及2034年）
  • 全球非处方药检测市场：依国家划分、实际及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • OTC检测市场：竞争格局
  • OTC测试市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • QuidelOrtho Corporation
  • Kroger Health
  • Dexcom Inc.
  • Bio-Rad Laboratories Inc.
  • SD Biosensor Inc.
  • OraSure Technologies Inc.
  • Everlywell Inc.
  • LetsGetChecked Inc.
  • Bionime Corporation
  • Nipro Diagnostics Inc.
  • Chembio Diagnostics Inc.
  • ACON Laboratories Inc.
  • iHealth Labs Inc.
  • Ellume Limited
  • Geratherm Medical AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年 OTC 检测市场：提供新机会的国家
  • 2029 年 OTC 检测市场：细分领域带来新机会
  • 2029 年 OTC 检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34107u

Over-the-counter (OTC) tests are diagnostic tests that consumers can purchase and use without a prescription. Designed for self-administration, these tests enable individuals to monitor or assess various aspects of their health without requiring a doctor's visit.

The primary types of OTC tests include cholesterol monitoring, urine analysis, drug abuse testing, infectious disease testing, fecal occult blood tests, and glucose monitoring. Cholesterol monitoring tests measure blood cholesterol and lipid levels to assess heart health and help prevent cardiovascular diseases. These tests are applied in cardiology, oncology, glucose monitoring, pregnancy and fertility, infectious disease detection, and toxicology. They serve various end users, including hospitals and clinics, home care settings, diagnostic laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The over the counter or OTC test market research report is one of a series of new reports from The Business Research Company that provides over the counter or OTC test market statistics, including the over the counter or OTC test industry global market size, regional shares, competitors with the over the counter or OTC test market share, detailed over the counter or OTC test market segments, market trends, and opportunities, and any further data you may need to thrive in the over the counter or OTC test industry. This over the counter or OTC test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over the counter or otc test market size has grown rapidly in recent years. It will grow from $24.1 billion in 2024 to $27.47 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to the rise of smart home healthcare, rising remote patient monitoring, the rise of outpatient clinics, the growth of mHealth (mobile health) solutions, and the rise of subscription-based services.

The over the counter or otc test market size is expected to see rapid growth in the next few years. It will grow to $45.96 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to the increasing prevalence of infectious diseases, increasing number of HIV-infected, rising remote patient monitoring, increasing penetration of smartphones, and rising healthcare-associated infections (HAIS). Major trends in the forecast period include the integration of digital health, integration with mobile apps, integrated care models, the integration of AI and machine learning, and remote infection control monitoring.

The forecast of 13.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. consumer health access by increasing costs for rapid COVID-19 and cholesterol test strips imported from China and Germany, potentially leading to reduced preventive screening and higher out-of-pocket expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the over-the-counter (OTC) test market. Chronic diseases, which persist for a year or more and require ongoing medical attention, are becoming more widespread due to factors such as aging populations, unhealthy lifestyles, environmental influences, and socioeconomic disparities. OTC tests play a crucial role in managing chronic diseases by enabling early detection, empowering individuals to monitor their health, and facilitating timely interventions, ultimately improving health outcomes through proactive care. For example, in January 2023, the National Center for Biotechnology Information (NCBI) projected that by 2050, the number of individuals aged 50 years and older with at least one chronic illness will rise by 99.5%, from 71.522 million in 2020 to 142.66 million. This growing disease burden is fueling demand for OTC diagnostic solutions.

Leading companies in the OTC test market are focusing on advancing at-home test kits to improve convenience, accuracy, and accessibility for consumers. At-home test kits enable individuals to diagnose specific health conditions from the comfort of their homes, often providing rapid results from blood, saliva, or urine samples. For instance, in December 2023, DiaCarta, a US-based molecular diagnostics company, received OTC approval for its iColon Fecal Occult Blood Test (FOBT) following US FDA 510(k) clearance. This innovative test facilitates early detection of blood in stool, a key indicator of gastrointestinal disorders and colorectal cancer-the third most common cancer worldwide. The iColon FOBT complements DiaCarta's existing ColoScape Test, further strengthening the company's commitment to improving early cancer detection and intervention.

In December 2024, OraSure Technologies, a US-based medical device company, acquired Sherlock Biosciences for an undisclosed amount. This strategic acquisition aims to enhance OraSure's diagnostic offerings by integrating Sherlock's advanced molecular diagnostics platform, which provides fast, accurate results in a disposable format ideal for home testing. The deal aligns with OraSure's broader objective of increasing healthcare access and affordability through innovative testing solutions. Sherlock Biosciences, a US-based manufacturer, specializes in OTC disposable molecular tests, particularly for sexually transmitted infections (STIs).

Major players in the over the counter or OTC test market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson and Company (BD), QuidelOrtho Corporation, Kroger Health, Dexcom Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., OraSure Technologies Inc., Everlywell Inc., LetsGetChecked Inc., Bionime Corporation, Nipro Diagnostics Inc., Chembio Diagnostics Inc., ACON Laboratories Inc., iHealth Labs Inc., Ellume Limited, Geratherm Medical AG, Wondfo Biotech Co. Ltd., bioLytical Laboratories Inc., Watmind USA, First Check Diagnostics LLC.

North America was the largest region in the over the counter or OTC test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter or OTC test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over the counter or OTC test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) tests market consists of sales of blood glucose meters, fingerstick cholesterol test kits, skin prick allergy tests, and blood pressure monitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter Or OTC Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter or otc test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for over the counter or otc test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The over the counter or otc test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Cholesterol Monitoring Test; Urine Analysis Test; Drug Abuse Test; Infectious Disease Testing; Fecal Occult Test; Glucose Monitoring Test
  • 2) By Application: Cardiology; Oncology; Glucose Monitoring; Pregnancy And Fertility; Infectious Disease; Toxicology
  • 3) By End-User: Hospital And Clinic; Home Care; Diagnostic Laboratory; Other End-Users
  • Subsegments:
  • 1) By Cholesterol Monitoring Test: Total Cholesterol Test; HDL (High-Density Lipoprotein) Test; LDL (Low-Density Lipoprotein) Test; Triglycerides Test
  • 2) By Urine Analysis Test: Urine Dipstick Test; Urine Microscopy Test; Urine Culture Test; Urine Pregnancy Test
  • 3) By Drug Abuse Test: Urine Drug Test; Saliva Drug Test; Hair Follicle Drug Test; Breath Drug Test
  • 4) By Infectious Disease Testing: HIV Test; Hepatitis Test; Influenza Test; COVID-19 Test; Strep Throat Test
  • 5) By Fecal Occult Test: Guaiac-Based Fecal Occult Blood Test (gFOBT); Immunochemical Fecal Occult Blood Test (iFOBT/FIT)
  • 6) By Glucose Monitoring Test: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Systems; Urine Glucose Test Strips
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Siemens Healthineers AG; Becton, Dickinson and Company (BD); QuidelOrtho Corporation; Kroger Health; Dexcom Inc.; Bio-Rad Laboratories Inc.; SD Biosensor Inc.; OraSure Technologies Inc.; Everlywell Inc.; LetsGetChecked Inc.; Bionime Corporation; Nipro Diagnostics Inc.; Chembio Diagnostics Inc.; ACON Laboratories Inc.; iHealth Labs Inc.; Ellume Limited; Geratherm Medical AG; Wondfo Biotech Co. Ltd.; bioLytical Laboratories Inc.; Watmind USA; First Check Diagnostics LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Over The Counter Or OTC Test Market Characteristics

3. Over The Counter Or OTC Test Market Trends And Strategies

4. Over The Counter Or OTC Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Over The Counter Or OTC Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Over The Counter Or OTC Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Over The Counter Or OTC Test Market Growth Rate Analysis
  • 5.4. Global Over The Counter Or OTC Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Over The Counter Or OTC Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Over The Counter Or OTC Test Total Addressable Market (TAM)

6. Over The Counter Or OTC Test Market Segmentation

  • 6.1. Global Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cholesterol Monitoring Test
  • Urine Analysis Test
  • Drug Abuse Test
  • Infectious Disease Testing
  • Fecal Occult Test
  • Glucose Monitoring Test
  • 6.2. Global Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology
  • Oncology
  • Glucose Monitoring
  • Pregnancy And Fertility
  • Infectious Disease
  • Toxicology
  • 6.3. Global Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinic
  • Home Care
  • Diagnostic Laboratory
  • Other End-Users
  • 6.4. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Cholesterol Monitoring Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Cholesterol Test
  • HDL (High-Density Lipoprotein) Test
  • LDL (Low-Density Lipoprotein) Test
  • Triglycerides Test
  • 6.5. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Urine Analysis Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Dipstick Test
  • Urine Microscopy Test
  • Urine Culture Test
  • Urine Pregnancy Test
  • 6.6. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Drug Abuse Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Test
  • Saliva Drug Test
  • Hair Follicle Drug Test
  • Breath Drug Test
  • 6.7. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HIV Test
  • Hepatitis Test
  • Influenza Test
  • COVID-19 Test
  • Strep Throat Test
  • 6.8. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Fecal Occult Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac-Based Fecal Occult Blood Test (gFOBT)
  • Immunochemical Fecal Occult Blood Test (iFOBT/FIT)
  • 6.9. Global Over The Counter Or OTC Test Market, Sub-Segmentation Of Glucose Monitoring Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring (CGM) Systems
  • Urine Glucose Test Strips

7. Over The Counter Or OTC Test Market Regional And Country Analysis

  • 7.1. Global Over The Counter Or OTC Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Over The Counter Or OTC Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Over The Counter Or OTC Test Market

  • 8.1. Asia-Pacific Over The Counter Or OTC Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Over The Counter Or OTC Test Market

  • 9.1. China Over The Counter Or OTC Test Market Overview
  • 9.2. China Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Over The Counter Or OTC Test Market

  • 10.1. India Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Over The Counter Or OTC Test Market

  • 11.1. Japan Over The Counter Or OTC Test Market Overview
  • 11.2. Japan Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Over The Counter Or OTC Test Market

  • 12.1. Australia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Over The Counter Or OTC Test Market

  • 13.1. Indonesia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Over The Counter Or OTC Test Market

  • 14.1. South Korea Over The Counter Or OTC Test Market Overview
  • 14.2. South Korea Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Over The Counter Or OTC Test Market

  • 15.1. Western Europe Over The Counter Or OTC Test Market Overview
  • 15.2. Western Europe Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Over The Counter Or OTC Test Market

  • 16.1. UK Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Over The Counter Or OTC Test Market

  • 17.1. Germany Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Over The Counter Or OTC Test Market

  • 18.1. France Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Over The Counter Or OTC Test Market

  • 19.1. Italy Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Over The Counter Or OTC Test Market

  • 20.1. Spain Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Over The Counter Or OTC Test Market

  • 21.1. Eastern Europe Over The Counter Or OTC Test Market Overview
  • 21.2. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Over The Counter Or OTC Test Market

  • 22.1. Russia Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Over The Counter Or OTC Test Market

  • 23.1. North America Over The Counter Or OTC Test Market Overview
  • 23.2. North America Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Over The Counter Or OTC Test Market

  • 24.1. USA Over The Counter Or OTC Test Market Overview
  • 24.2. USA Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Over The Counter Or OTC Test Market

  • 25.1. Canada Over The Counter Or OTC Test Market Overview
  • 25.2. Canada Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Over The Counter Or OTC Test Market

  • 26.1. South America Over The Counter Or OTC Test Market Overview
  • 26.2. South America Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Over The Counter Or OTC Test Market

  • 27.1. Brazil Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Over The Counter Or OTC Test Market

  • 28.1. Middle East Over The Counter Or OTC Test Market Overview
  • 28.2. Middle East Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Over The Counter Or OTC Test Market

  • 29.1. Africa Over The Counter Or OTC Test Market Overview
  • 29.2. Africa Over The Counter Or OTC Test Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Over The Counter Or OTC Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Over The Counter Or OTC Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Over The Counter Or OTC Test Market Competitive Landscape And Company Profiles

  • 30.1. Over The Counter Or OTC Test Market Competitive Landscape
  • 30.2. Over The Counter Or OTC Test Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Over The Counter Or OTC Test Market Other Major And Innovative Companies

  • 31.1. QuidelOrtho Corporation
  • 31.2. Kroger Health
  • 31.3. Dexcom Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. SD Biosensor Inc.
  • 31.6. OraSure Technologies Inc.
  • 31.7. Everlywell Inc.
  • 31.8. LetsGetChecked Inc.
  • 31.9. Bionime Corporation
  • 31.10. Nipro Diagnostics Inc.
  • 31.11. Chembio Diagnostics Inc.
  • 31.12. ACON Laboratories Inc.
  • 31.13. iHealth Labs Inc.
  • 31.14. Ellume Limited
  • 31.15. Geratherm Medical AG

32. Global Over The Counter Or OTC Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter Or OTC Test Market

34. Recent Developments In The Over The Counter Or OTC Test Market

35. Over The Counter Or OTC Test Market High Potential Countries, Segments and Strategies

  • 35.1 Over The Counter Or OTC Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Over The Counter Or OTC Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Over The Counter Or OTC Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer